Company news
Nanexa AB news in 2025
Nanexa AB's news releases, calls and decks from 2025, newest first.
Nanexa and Moderna enter into license and option agreement for the development of PharmaShell®-based products
December 10, 2025
Nanexa publishes interim report for January-September 2025
November 6, 2025
Nanexa AB changes Certified Adviser to Tapper Partners AB
October 1, 2025
Nanexa receives Japanese patent approval for specific PharmaShell structure
September 22, 2025
Nanexa publishes interim report for January-June 2025
August 27, 2025
Nanexa Signs Continuation of Feasibility Agreement with Major Pharmaceuticals Company to Investigate PharmaShell® Long-Acting Formulations in a Multi-Billion USD Market
August 8, 2025
Calls in 2025
Decks in 2025
- Q2 2025 Earnings Presentation
Earnings · 14 slides · Aug 27, 2025